The heterogeneity of the DNA damage response landscape determines patient outcomes in ovarian cancer

TDJ Walker(University of Manchester), Richard J. Edmondson(Manchester Academic Health Science Centre)

bioRxiv (Cold Spring Harbor Laboratory)

August 5, 2021

10.1101/2021.08.03.454868

Cited by 0

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

|Nature reviews. Cancer|2015|1.4k

The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome

|British Journal of Cancer|2023|9